Publish in this journal
Journal Information
Vol. 61. Issue 6.
Pages 561-563 (June 2008)
Full text access
QT Interval and Acute Myocardial Ischemia: Past Promises, New Evidences
Intervalo QT e isquemia miocárdica aguda: viejas promesas, nuevas evidencias
Visits
...
Javier Jiménez Candila, Cándido Martín Luengoa
a Servicio de Cardiología, Hospital Universitario de Salamanca, Salamanca, Spain
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
An ever-increasing number of individuals are being treated for non-ST-elevation acute coronary syndrome (NSTEACS). The clinical profile of these patients is highly heterogeneous, and the incidence of serious adverse events varies widely.1 Thus, stratification of these patients on the basis of prognosis is an enormous challenge because it should be rapid, accurate and efficient in order to enable the early identification of patients at significant risk for a poorer outcome. Their subsequent management should be adjusted to their initial prognostic profile, once it has been defined; more aggressive medical and interventional therapies are applied in those patients in whom the available scientific evidence is indicative, a priori, of a higher risk.

In this context, given its universal availability, low cost and simplicity, the electrocardiogram is a basic "bedside" tool that provides highly important, and early, information.2 Indeed, a number of reports have consistently demonstrated the negative short-term and long-term prognostic implications of the presence (and magnitude) of ST depression in the electrocardiogram performed at admission. We know, however, that in 34% to 54% of the patients with NSTEACS, the ST segment shows no evidence of changes upon their arrival at the hospital, and that, once again, the subsequent course is highly variable.3 This explains the interest in the study of other electrocardiographic parameters that could provide additional information that would complement the ST segment analysis, such as QRS complex duration,4 T wave abnormalities,5 or duration of the corrected QT interval,6,7 the utility of which has been demonstrated in some series, mostly involving smaller groups of patients from a single center.

QT Interval and Myocardial Ischemia: From the Cell to the Patient's Bedside

The QT interval is determined in the electrocardiogram from the beginning of the QRS complex (whether it starts with a Q wave or an R wave) to the point at which the T wave (or the U wave, if present) returns to the isoelectric line. Thus, it includes the duration of ventricular depolarization and repolarization, and corresponds to the action potential duration.

In a number of epidemiological studies involving theoretically healthy individuals, the ventricular repolarization abnormalities in the electrocardiogram (not only the ST segment deviations, but changes in T wave morphology and QT interval prolongation as well) have been associated with an increased risk of sudden death8 and of cardiovascular death,9 probably because they could be markers of ventricular hypertrophy, left ventricular dysfunction or myocardial ischemia.10

Acute myocardial ischemia has been shown to modify the duration of the QT interval, increase repolarization heterogeneity (expressed as an increase in QT dispersion) and prolong the duration of the maximum electrocardiographic QT interval.11 Several mechanisms have been proposed to be involved in the prolongation of the QT interval secondary to acute myocardial ischemia: changes in the myocardial response to catecholamines or to cholinergic stimulation, perturbation of calcium or potassium ion channels, or induction of changes in the intracellular hydrogen concentration.

Beyond the basic mechanisms, clinical interest in this causal relationship is long-standing, and the observation that acute transmural myocardial ischemia prolonged the QT interval,12 and that this increase in the QT interval following Q wave acute myocardial infarction was associated with a significantly higher risk for sudden death,13 are findings that were reported in the eighties. More recently, Nowinski et al14 demonstrated that the myocardial ischemia occurring during balloon inflation in percutaneous transluminal coronary angioplasty immediately produced changes in ventricular repolarization, including a significant prolongation in the QT interval that persisted for minutes, or even hours.15 These findings suggest the possibility of employing the QT interval as an early marker of acute and transient myocardial ischemia.

However, the possible clinical applications of the previous experimental data in patients with NSTEACS arrived only a relatively short time ago. Recently, in 2 series involving consecutive, unselected patients with a diagnosis of NSTEACS, the prognostic value of the corrected QT (QTc) interval at admission7 and the maximum QTc interval during the first 48 hours were determined, and it was observed that values over 450 milliseconds were significantly associated with an increase in the incidence of major short-term6,7 and long-term7 adverse events. In contrast to the findings reported following transmural myocardial infarction, the negative impact on prognosis of a prolonged QTc interval in NSTEACS was not associated with a higher risk for sudden death presumably due to ventricular arrhythmias,13 but due to an increase in the incidence of new onset acute coronary syndromes.7 This circumstance suggests that, in NSEACS, the prolongation of the QTc interval could depend on: a) the extension of subclinical atherosclerotic coronary artery disease; or b) the severity of the underlying myocardial ischemia. There is insufficient scientific evidence to support the first hypothesis, despite the fact that there are data that appear to point in that direction. In this respect, it has been demonstrated that there is a significant positive correlation between the duration of the QT interval and the carotid artery intimal thickness in apparently healthy nondiabetic subjects.16 It could be that certain cytokines associated with endothelial dysfunction of incipient atherosclerosis that have an effect on the ventricular action potential are implicated in the prolongation of the QT interval.13 With respect to the second hypothesis, our group has recently reported that in patients treated in the emergency room for acute chest pain of probable cardiac origin who have a low-risk clinical profile, the duration of the QTc interval at admission was correlated significantly and independently with the extension of the myocardial ischemia, observed in a provocation test (ergometry or SPECT) performed within 5 days; again, a QTc duration of 450 milliseconds or more selected the individuals at higher risk for myocardial ischemia defined as moderate or severe.17

Along the aforementioned line, the interesting study by Gadaleta et al18 published in this issue of Revista Española de Cardiología provides new evidence in support of the long-recognized relationship between the QTc interval and acute myocardial ischemia that is, in our opinion, of particular interest, since it focuses on patients with a diagnosis of NSTEACS in whom there are no electrocardiographic abnormalities indicative of acute ischemia at admission.

In agreement with the findings recently reported by our group,19 these authors demonstrate that a QTc interval with a duration of more than 458 milliseconds, detected within the first 24 hours of admission, with no electrocardiographic evidence of ST-T changes, serves as an independent risk marker and is related to a significant increase in the probability of adverse events (death, infarction, or coronary revascularization) within the first 28 days of the onset of the symptoms. In our opinion, there are 3 aspects of this report on which particular emphasis should be placed: on the one hand, the high incidence (38%) of adverse events observed, taking into account the selection criteria employed in the study, which highlights the degree of heterogeneity of populations with acute coronary syndrome and an isoelectric ST segment at admission; on the other hand, the reproducibility of the QTc value beyond which the risk for a complicated clinical course increases (around 450-460 milliseconds); finally, the correlation observed between the duration of the QTc interval and the maximum troponin T concentrations, which, as the authors themselves point out, makes it possible to move up a rung in the understanding of the complex pathophysiological relationship between the QT interval and acute myocardial ischemia and its severity.

It is still necessary to clarify certain questions that will determine whether or not the use of the QT interval will eventually be employed in the stratification of patients with NSTEACS in terms of prognosis. Thus, we will need larger series of patients to examine the reproducibility of the data and their impact on the prognosis, and to rule out the existence of significant interobserver and intraobserver variability with regard to QTc values. The availability of these measurements in computerized form might solve the problem, although with the data we have at the present time, we can not ensure that the measurements of the QT interval not carried out manually are more accurate.20

Moreover, it would be advisable to demonstrate the independence of the QT interval values from the heart rate, because the QT interval is usually adjusted to the heart rate using the Bazett formula and, although this adjustment is certainly accurate for heart rates within normal range (60 to 100 beats/minute), it is less so for measurements taken at higher heart rates, in which the QTc value is over estimated. Thus, other formulas have been developed to correct the QT interval on the basis of the heart rate. However, while they are highly accurate, in practice, they are almost never employed.21

Meanwhile, in these times of numerous biological markers and of increasingly sophisticated diagnostic tests, a simple, long recognized variable, easy to obtain in that old electrocardiogram, is making advances in the stratification of patients with NSTEACS according to prognosis. It is a welcome development.

SEE ARTICLE ON PAGES 572-8
Correspondence:
Dr. C. Martín Luengo.
Servicio de Cardiología. Hospital Universitario. P.o de San Vicente, 58-182. 37007 Salamanca. España.
E-mail: cmluengo@usal.es
Bibliography
[1]
Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, et al..
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction..
J Am Coll Cardiol, 26 (1995), pp. 1643-50
[2]
Medeiros-Domingo A, Iturralde-Torres P, Ackerman MJ..
Características clínicas y genéticas del síndrome de QT largo..
Rev Esp Cardiol, 60 (2007), pp. 739-52
[3]
Kaul P, Newby LK, Fu Y, Hasselblad V, Mahaffey KW, Christenson RH, et al..
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients..
J Am Coll Cardiol, 41 (2003), pp. 371-80
[4]
Jimenez-Candil J, Cruz Gonzalez I, Martin F, Pabon P, Leon V, Hernandez J, et al..
Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome. Int J Cardio, 126 (2008), pp. 196-203
[5]
Jacobsen MD, Wagner GS, Holmvang L, Kontny F, Wallentin L, Husted S, et al..
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population..
Eur Heart J, 26 (2005), pp. 112-8
[6]
Gadaleta FL, Llois SC, Lapuente AR, Batchvarov VN, Kaski JC..
Prognostic value of corrected QT-interval prolongation in patients with unstable angina pectoris..
Am J Cardiol, 92 (2003), pp. 203-5
[7]
Jimenez-Candil J, Gonzalez IC, Gonzalez Matas JM, Albarran C, Pabon P, Morinigo JL, et al..
Short- and long-term prognostic value of the corrected QT interval in the non-ST-elevation acute coronary syndrome..
J Electrocardiol, 40 (2007), pp. 180-7
[8]
Straus SM, Kors JA, de Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al..
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults..
J Am Coll Cardiol, 47 (2006), pp. 362-7
[9]
de Bacquer D, de Backer G, Kornitzer M, Blackburn H..
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women..
Heart, 80 (1998), pp. 570-7
[10]
Lehmann MH, Morady F..
QT interval:metric for cardiac prognosis? Am J Med, 115 (2003), pp. 732-4
[11]
Bijl M, Verheugt FW..
Extreme QT prolongation solely due to reversible myocardial ischemia in single-vessel coronary disease..
Am Heart J, 123 (1992), pp. 524-6
[12]
Cinca J, Figueras J, Tenorio L, Valle V, Trenchs J, Segura R, et al..
Time course and rate dependence of Q-T interval changes during noncomplicated acute transmural myocardial infarction in human beings..
Am J Cardiol, 48 (1981), pp. 1023-8
[13]
Schwartz PJ, Wolf S..
QT interval prolongation as predictor of sudden death in patients with myocardial infarction..
Circulation, 57 (1978), pp. 1074-7
[14]
Nowinski K, Jensen S, Lundahl G, Bergfeldt L..
Changes in ventricular repolarization during percutaneous transluminal coronary angioplasty in humans assessed by QT interval, QT dispersion and T vector loop morphology..
J Intern Med, 248 (2000), pp. 126-36
[15]
Shawl FA, Velasco CE, Goldbaum TS, Forman MB..
Effect of coronary angioplasty on electrocardiographic changes in patients with unstable angina secondary to left anterior descending coronary artery disease..
J Am Coll Cardiol, 16 (1990), pp. 325-31
[16]
Festa A, D'Agostino R Jr, Rautaharju P, O'Leary DH, Rewers M, Mykkanen L, et al..
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS)..
Stroke, 30 (1999), pp. 1566-71
[17]
Jimenez-Candil J, Diego M, Cruz Gonzalez I, Gonzalez Matas JM, Martin F, Pabon P, et al..
Relationship between the QTc interval at hospital admission and the severity of the underlying ischaemia in low and intermediate risk people studied for acute chest pain..
Int J Cardiol, 126 (2008), pp. 84-91
[18]
Gadaleta FL, Llois SC, Sinisi VA, Quiles J, Avanzas P, Kaski JC..
Prolongación del intervalo QT corregido: nuevo predictor de riesgo cardiovascular en el síndrome coronario agudo sin elevación del ST..
Rev Esp Cardiol, 61 (2008), pp. 572-8
[19]
Significado pron??stico del intervalo QTc en pacientes con un s??ndrome coronario agudo sin elevaci??n del ST y electrocardiograma normal al ingreso. Rev Esp Cardiol. 2007;60 Supl 2:192.
[20]
Electrocardiography. In: Topol EJ, editor. Textbook of Cardiovascular Medicine. 3rd ed. Philadelphia: Lippincott Williams & Williams; 2007. p. 984.
[21]
Rautaharju PM, Zhou SH, Wong S, Prineas R, Berenson GS..
Functional characteristics of QT prediction formulas. The concepts of QTmax and QT rate sensitivity..
Comput Biomed Res, 26 (1993), pp. 188-204
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.